BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 30217580)

  • 1. Long-term outcome of MR-guided focused ultrasound treatment and laparoscopic myomectomy for symptomatic uterine fibroid tumors.
    Mohr-Sasson A; Machtinger R; Mashiach R; Nir O; Inbar Y; Maliyanker N; Goldenberg M; Rabinovici J
    Am J Obstet Gynecol; 2018 Oct; 219(4):375.e1-375.e7. PubMed ID: 30217580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry.
    Laughlin-Tommaso SK; Lu D; Thomas L; Diamond MP; Wallace K; Wegienka G; Vines AI; Anchan RM; Wang T; Maxwell GL; Jacoby V; Marsh EE; Spies JB; Nicholson WK; Stewart EA; Myers ER
    Am J Obstet Gynecol; 2020 Apr; 222(4):345.e1-345.e22. PubMed ID: 31678093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-guided high-intensity focused ultrasound vs laparoscopic myomectomy for symptomatic uterine myomas.
    Wang F; Tang L; Wang L; Wang X; Chen J; Liu X; Gong Y
    J Minim Invasive Gynecol; 2014; 21(2):279-84. PubMed ID: 24075837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis.
    Barnard EP; AbdElmagied AM; Vaughan LE; Weaver AL; Laughlin-Tommaso SK; Hesley GK; Woodrum DA; Jacoby VL; Kohi MP; Price TM; Nieves A; Miller MJ; Borah BJ; Gorny KR; Leppert PC; Peterson LG; Stewart EA
    Am J Obstet Gynecol; 2017 May; 216(5):500.e1-500.e11. PubMed ID: 28063909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term risk of fibroid recurrence after laparoscopic myomectomy.
    Radosa MP; Owsianowski Z; Mothes A; Weisheit A; Vorwergk J; Asskaryar FA; Camara O; Bernardi TS; Runnebaum IB
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():35-9. PubMed ID: 25016181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids.
    Jacoby VL; Kohi MP; Poder L; Jacoby A; Lager J; Schembri M; Rieke V; Grady D; Vittinghoff E; Coakley FV
    Fertil Steril; 2016 Mar; 105(3):773-780. PubMed ID: 26658133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance-guided focused ultrasound myomectomy: safety, efficacy, subsequent fertility and quality-of-life improvements, a systematic review.
    Gizzo S; Saccardi C; Patrelli TS; Ancona E; Noventa M; Fagherazzi S; Mozzanega B; D'Antona D; Nardelli GB
    Reprod Sci; 2014 Apr; 21(4):465-76. PubMed ID: 23868442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospective study on magnetic resonance-guided focused ultrasound surgery for symptomatic uterine fibroid: short-term follow up].
    Fan R; Zhu L; Gong XM; Xue HD; Shi HF; Jin ZY; Chen GJ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Mar; 48(3):183-7. PubMed ID: 23849940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of magnetic resonance-Guided focused ultrasound surgery (MRgFUS) for FIGO class 1 fibroids.
    Mashiach R; Inbar Y; Rabinovici J; Mohr Sasson A; Alagem-Mizrachi A; Machtinger R
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():119-122. PubMed ID: 29288921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids.
    Anchan RM; Spies JB; Zhang S; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
    Am J Obstet Gynecol; 2023 Sep; 229(3):275.e1-275.e17. PubMed ID: 37244458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency Thermal Ablation for Uterine Myomas: Long-term Clinical Outcomes and Reinterventions.
    Iversen H; Dueholm M
    J Minim Invasive Gynecol; 2017; 24(6):1020-1028. PubMed ID: 28662989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery.
    Laughlin-Tommaso S; Barnard EP; AbdElmagied AM; Vaughan LE; Weaver AL; Hesley GK; Woodrum DA; Jacoby VL; Kohi MP; Price TM; Nieves A; Miller MJ; Borah BJ; Moriarty JP; Gorny KR; Leppert PC; Severson AL; Lemens MA; Stewart EA
    Am J Obstet Gynecol; 2019 Feb; 220(2):174.e1-174.e13. PubMed ID: 30696556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interim analysis of a randomized controlled trial comparing laparoscopic radiofrequency volumetric thermal ablation of uterine fibroids with laparoscopic myomectomy.
    Krämer B; Hahn M; Taran FA; Kraemer D; Isaacson KB; Brucker SY
    Int J Gynaecol Obstet; 2016 May; 133(2):206-11. PubMed ID: 26892690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot Study of the Mirabilis System Prototype for Rapid Noninvasive Uterine Myoma Treatment Using an Ultrasound-Guided Volumetric Shell Ablation Technique.
    Parsons JE; Lau MPH; Martin PJ; Islas Lagos JJ; Aguilar Aguirre JM; Garza Leal JG
    J Minim Invasive Gynecol; 2017; 24(4):579-591. PubMed ID: 28109895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility, Safety, and Efficacy of Accurate Uterine Fibroid Ablation Using Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound With Shot Sonication.
    Xu Y; Fu Z; Yang L; Huang Z; Chen WZ; Wang Z
    J Ultrasound Med; 2015 Dec; 34(12):2293-303. PubMed ID: 26518278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis.
    Verpalen IM; Anneveldt KJ; Nijholt IM; Schutte JM; Dijkstra JR; Franx A; Bartels LW; Moonen CTW; Edens MA; Boomsma MF
    Eur J Radiol; 2019 Nov; 120():108700. PubMed ID: 31634683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US therapy.
    Park MJ; Kim YS; Rhim H; Lim HK
    J Vasc Interv Radiol; 2014 Feb; 25(2):231-9. PubMed ID: 24360886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Comparison of Life Quality between Ultrasound-Guided High-Intensity Focused Ultrasound and Laparoscopic Myomectomy for the Treatment of Uterine Fibroids.
    Yuan B; Qin X; Xi J
    Comput Math Methods Med; 2022; 2022():9604915. PubMed ID: 36035293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of sonographically guided high-intensity focused ultrasound for symptomatic uterine fibroids: preliminary study of a modified protocol.
    Leung JH; Yu SC; Cheung EC; Wong AS; Tong MM; Ho SS; Leung VY; Ahuja AT
    J Ultrasound Med; 2014 Oct; 33(10):1811-8. PubMed ID: 25253828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
    Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
    Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.